Marcus-Hillert Schultze-Mosgau
8PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jun 26, 2025
The Effects of Elinzanetant on Simulated Driving Performance in Healthy Women: A Randomized Phase I Study.Klaus Francke, Stefan Klein, Jennifer Burke
|Dec 18, 2023
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling.Friederike Kanefendt, André Dallmann, Huijun Chen
|Oct 12, 2021
Single- and Multiple-Dose Pharmacokinetics and Safety of Vilaprisan in Healthy Postmenopausal Japanese Women: A Randomized Clinical Trial.Marcus-Hillert Schultze-Mosgau, Shunji Matsuki, Kazuhito Okumura
|Sep 27, 2021
Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview.Marcus-Hillert Schultze-Mosgau, Bart A Ploeger, Matthias Frei
|Jul 30, 2021
Assessment of the safe and efficacious dose of the selective progesterone receptor modulator vilaprisan for the treatment of patients with uterine fibroids by exposure-response modelling and simulation.Gabriele Sutter, Matthias Frei, Marcus-Hillert Schultze-Mosgau
|Jun 28, 2020
The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive-A randomized controlled trial.Marcus-Hillert Schultze-Mosgau, Barbara Schütt, Corinna Draeger
Pageof 2
